“The stool and both respiratory specimens later tested positive by rRT-PCR for 2019-nCoV, whereas the serum remained negative.” Can’t emphasize effective handwashing enough... up until now, only respiratory secretions have been discussed.
-
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
"Clinicians pursued compassionate use of an investigational antiviral therapy. Treatment with intravenous remdesivir (a novel nucleotide analogue prodrug in development) was initiated on the evening of day 7"
#IDTwitter#nCoV2019 - Još 1 odgovor
Novi razgovor -
-
-
In addition to upper respiratory symptoms and positive tests for 2019-nCoV from nasopharyngeal swabs, passing loose stools for two days and testing positive for 2019-nCoV in stool specimens suggest that 2019-nCoV may have tropism for the upper & lower resp. and the GI tracts...
-
Tropism of the 2019-nCoV may be an important clue to point at its receptor on the host. This may help researches in finding out therapeutic & prophylactic agents...
Kraj razgovora
Novi razgovor -
-
-
Thanks to NEJM that offer these Articles about 2019-nCov free for all physicians around the world. Job well done
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
What’s the update!?
-
Same query here!
- Još 1 odgovor
Novi razgovor -
-
-
Very useful info
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
@vanranstmarc experimenteel antiviraal middel geven als de patiënt nog saturaties van 90% heeft en alg stabiel is? Wat is uw mening hierover?Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.